SPM Corporation (HOSE:SPM)
8,890.00
0.00 (0.00%)
At close: Nov 2, 2026
SPM Corporation Revenue
SPM Corporation had revenue of 51.79B VND in the quarter ending September 30, 2026, a decrease of -21.11%. This brings the company's total for the last twelve months to 202.60B, down -31.32% year-over-year. In the year 2025, SPM Corporation had annual revenue of 253.96B, down -14.72%. That makes SPM Corporation the 38,379th largest company in the world by revenue and 563rd in Vietnam.
Revenue (ttm)
202.60B
Revenue Growth
-31.32%
P/S Ratio
0.60
Revenue / Employee
810.40M
Employees
250
Market Cap
122.42B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SPM Corporation breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 253.96B | -43.82B | -14.72% |
| Dec 31, 2024 | 297.78B | -108.33B | -26.68% |
| Dec 31, 2023 | 406.10B | -293.53B | -41.95% |
| Dec 31, 2022 | 699.63B | -10.26B | -1.44% |
| Dec 31, 2021 | 709.89B | 99.90B | 16.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 1.01T |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Pharmedic Pharmaceutical Medicinal JSC | 565.40B |
| Central Pharmaceutical Joint Stock Company No3 | 524.41B |
| Mediplantex National Pharmaceutical JSC | 434.97B |
| Vimedimex Medi-Pharma JSC | 310.29B |
| Lamdong Pharmaceutical JSC | 278.17B |
| Phong Phu Pharmaceutical JSC | 167.82B |